Entera Bio's Unattributed Round

Entera Bio raised a round of funding on October 19, 2017.

Entera Bio (NASDAQ: ENTX) is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug …

Articles about Entera Bio's Unattributed Round: